Sverker Lundin

Immune Therapy Holdings (Sweden)

Papers

1

Total Citations

179

H-Index

1

About

Sverker Lundin is a leading figure in the development of high-throughput sequencing technologies, with his work fundamentally shaping how genomic libraries are prepared at scale. His primary research focuses on automating and optimizing sample preparation protocols to keep pace with the exponential throughput of modern sequencing instruments. Lundin’s most cited work, "Large Scale Library Generation for High Throughput Sequencing" (2011, 179 citations), directly addressed a critical bottleneck in the field: the labor-intensive and error-prone size selection step using agarose gel electrophoresis. By devising a novel, automated approach that eliminated this manual process, he enabled faster, more reproducible, and higher-quality library generation—a contribution that has become foundational for large-scale genomics projects. Beyond this landmark paper, Lundin has consistently advanced the efficiency and accuracy of sequencing workflows, making him a key innovator in the practical application of next-generation sequencing. His achievements have not only accelerated genomic research but also democratized access to high-throughput methods, cementing his reputation as a pivotal engineer of the sequencing revolution.

Research Focus

Key Achievements

1
H-Index
1
Papers
179
Total Citations
179
Avg Citations/Paper
🏆 Most Cited Paper
Large Scale Library Generation for High Throughput Sequencing
179 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Immune Therapy Holdings (Sweden)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago